RTW Biotech Opportunities (LON:RTW) Trading Down 0.5% – Time to Sell?

RTW Biotech Opportunities (LON:RTW) was down 0.5% during trading on Tuesday . The stock traded as low as GBX 2.51 and last traded at GBX 2.53. Approximately 696,913 shares were traded during trading, a decline of 2% from the average session volume of 713,898 shares. The stock had previously closed at GBX 2.54.

RTW Biotech Opportunities Price Performance

The firm has a market cap of £8.16 million, a P/E ratio of 0.04 and a beta of 0.77. The company has a debt-to-equity ratio of 20.05, a current ratio of 0.15 and a quick ratio of 0.81. The stock’s 50-day simple moving average is GBX 2.44 and its two-hundred day simple moving average is GBX 2.22.

RTW Biotech Opportunities Company Profile

RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.